ARCHIVES

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

This article is from The Cancer Letter archive.

Vol. 36 No. 33 | September 17, 2010

Download PDF Visit The Full Archive

Related Articles

NCAB Criticizes Coverage’ Of NCI Screening Statement

March 4, 1994

In Brief: Shubik, Rhoads, Dixon Affiliations With Industry Lister By House Subcommittee

June 11, 1976

Long-Term Results Of STAR Find Raloxifene Causes Fewer, Less Severe Side Effects

April 30, 2010

Rosenberg: Immunotherapy May Have Broad Potential

June 24, 2005

NCI-Approved Clinical Trials

February 24, 2006

ACS Study Finds Low Tar Cigarettes Cause Few Lung Abnormalities

March 2, 1979